What PRN medication regimen (drug, dose, and frequency) is appropriate for severe agitation and delirium in an 82‑year‑old obese patient?

PRN Medication for Severe Agitation and Delirium in an 82-Year-Old Obese Patient

For an 82-year-old obese patient with severe agitation and delirium, start with haloperidol 0.5 mg orally or subcutaneously every 2 hours as needed, with a maximum of 5 mg daily in elderly patients. 1

First-Line Approach: Haloperidol

Haloperidol is the preferred first-line agent based on NICE guidelines specifically addressing elderly patients with delirium 1:

• Initial dose: 0.5–1 mg orally at night and every 2 hours when required
• Maximum daily dose: 5 mg in elderly patients (10 mg in younger adults)
• Dose titration: Increase in 0.5–1 mg increments as required
• Route flexibility: Can be given orally or subcutaneously at the same dose

Special Considerations for This Patient:

Start at the lower end (0.5 mg) given the patient's age of 82 years. The guidelines explicitly recommend reduced dosing in elderly patients 1, 2. Obesity does not require dose adjustment for haloperidol, as research shows no significant difference in antipsychotic dosing needs between obese and non-obese agitated patients 3.

Important Caveats:

• Do NOT use haloperidol if the patient has Parkinson's disease or dementia with Lewy bodies due to severe extrapyramidal side effect risk 2
• Monitor for QTc prolongation, especially in elderly patients 1, 2
• Watch for extrapyramidal symptoms; if they occur, reduce dose or switch agents 4

If Haloperidol Fails or Is Contraindicated

Add Lorazepam for Refractory Agitation:

If agitation persists despite haloperidol, add lorazepam 0.25–0.5 mg orally every 4–6 hours as needed (maximum 2 mg in 24 hours in elderly patients) 1:

• The guideline specifically states to reduce the standard dose (0.5–1 mg) to 0.25–0.5 mg in elderly or debilitated patients
• Can be given sublingually (off-label)
• Critical warning: Benzodiazepines, particularly midazolam, pose excessive risk in older adults with a 5-fold increased risk of adverse events compared to haloperidol 5

Alternative Antipsychotic Options:

If haloperidol is not tolerated, consider these alternatives with elderly-specific dosing 2:

Olanzapine:

• Start: 2.5 mg orally or subcutaneously at bedtime
• PRN dosing possible
• Better tolerated than haloperidol but causes more sedation and orthostatic hypotension
• Warning: Fatal interactions reported when combined with high-dose benzodiazepines 2

Quetiapine:

• Start: 12.5 mg orally twice daily (reduced from standard 25 mg due to age)
• More sedating but lower extrapyramidal symptom risk
• Safest option with lowest adverse event rate (OR 0.27 vs haloperidol) 5
• Oral route only

Risperidone:

• Start: 0.25 mg orally at bedtime (reduced from standard 0.5 mg)
• Can give up to twice daily if needed
• Higher extrapyramidal risk at doses >2 mg/day 4

If Patient Cannot Swallow

Levomepromazine 6.25–12.5 mg subcutaneously as starting dose, then hourly as required 1:

• The guideline specifically recommends using 6.25–12.5 mg in elderly patients (half the standard 12.5–25 mg dose)
• Can maintain with subcutaneous infusion of 50–200 mg over 24 hours
• More sedating with anticholinergic effects
• Consider adding midazolam if anxiety component present, but use extreme caution given the 5-fold increased adverse event risk in elderly 5

Critical Safety Points for This 82-Year-Old Patient:

1. Obesity does NOT require dose adjustment for these medications 3—age is the primary concern
2. Start low, go slow: Always use the lower end of dosing ranges 6
3. Avoid midazolam: Despite its inclusion in guidelines, recent evidence shows 53% adverse event rate in elderly with 5-fold increased risk vs haloperidol 5
4. Monitor closely: Elderly patients are at higher risk for falls, oversedation, respiratory depression, and paradoxical agitation 2, 5
5. Address reversible causes first: Check for hypoxia, urinary retention, constipation, medication effects before escalating pharmacotherapy 1

Practical PRN Regimen Summary:

Primary regimen:

• Haloperidol 0.5 mg PO/SC every 2 hours PRN (max 5 mg/24 hours)

If inadequate response after 2–3 doses:

• Add lorazepam 0.25 mg PO/SL every 4–6 hours PRN (max 2 mg/24 hours)

If still inadequate or haloperidol contraindicated:

• Switch to quetiapine 12.5 mg PO twice daily PRN (safest alternative) 5

If unable to swallow:

• Levomepromazine 6.25 mg SC hourly PRN

The evidence strongly supports haloperidol as first-line with age-adjusted dosing, avoiding benzodiazepine monotherapy due to excessive risk in this population 5, and recognizing that obesity itself does not necessitate dose modification 3.